Skip to main content
Year archive

Orexo — 2014 filings

All 64 regulatory filings released by Orexo (ORX) in 2014, sourced directly from the official regulator.

64 Filings
2014 Period
2014 filings (64)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-12-18 English
Orexo erhåller delmålsersättning på 5 miljoner GBP för Abstral® i Europa och Zubsolv® fortsätter den positiva försäljningsutvecklingen i USA
Regulatory Filings
2014-12-17 Swedish
Orexo receives million 5£ milestone payment for Abstral® in Europe and Zubsolv® continues strong market share growth in the US
Earnings Release FY 2014
2014-12-17 English
FDA godkänner två högre styrkor av Zubsolv®
Regulatory Filings
2014-12-12 Swedish
FDA approves two higher dosage strengths of ZUBSOLV®
Regulatory Filings
2014-12-12 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2014-11-28 Swedish
Number of shares and votes in Orexo
Share Issue/Capital Change
2014-11-28 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-10-24 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Q3 2014
2014-10-22 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report 9M 2014
2014-10-22 English
Invitation - Presentation of Orexo's third quarter results 2014
Report Publication Announcement
2014-10-15 English
Inbjudan - Presentation av Orexos resultat för tredje kvartalet 2014
Report Publication Announcement
2014-10-15 Swedish
Orexo submits application to FDA for expanded label of ZUBSOLV®
Regulatory Filings
2014-10-13 English
Orexo ansöker hos FDA om utökad användning av Zubsolv®
Legal Proceedings Report
2014-10-13 Swedish
Number of shares and votes in Orexo
Share Issue/Capital Change
2014-09-30 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2014-09-30 Swedish
Orexo has successfully completed its private placement of approx. SEK 346.5m
Share Issue/Capital Change
2014-08-29 English
Orexo har framgångsrikt genomfört en placering om cirka 346,5 MSEK
Share Issue/Capital Change
2014-08-29 Swedish
Orexo intends to conduct a private placement of shares to Swedish and international institutional and strategic investors
Capital/Financing Update
2014-08-28 English
Orexo avser att genomföra en placering av aktier till svenska och internationella institutionella och strategiska investerare
Capital/Financing Update
2014-08-28 Swedish
Orexo stärker sitt kommersiella fokus och ökar effektiviteten
Earnings Release FY 2014
2014-08-20 Swedish
Orexo enhances commercial focus and operating efficiencies
Earnings Release Q4 2014
2014-08-20 English
OX-MPI project returned to Orexo
Regulatory Filings
2014-08-06 English
OX-MPI projektet återlämnas till Orexo
Regulatory Filings
2014-08-06 Swedish
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2014-07-31 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2014-07-31 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report H1 2014
2014-07-11 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Q2 2014
2014-07-11 English
Orexo Added to Russell Global Index
Report Publication Announcement
2014-06-30 English
Orexo ingår nu i Russell Global Index
Regulatory Filings
2014-06-30 Swedish
Orexo stämmer Actavis för patentintrång
Legal Proceedings Report
2014-06-27 Swedish
Orexo commences patent infringement litigation against Actavis
Legal Proceedings Report
2014-06-27 English
Top-line data from a Phase 3 clinical trial demonstrates that Zubsolv® is as effective as Suboxone® film in the treatment of opioid dependence
Earnings Release FY 2014
2014-06-25 English
Klinisk studie visar att Zubsolv® (buprenorfin/naloxon sublingual tablett) är lika effektiv som Suboxone® film för behandling av opiatberoende
Regulatory Filings
2014-06-25 Swedish
Positive Top-line Results from Two Phase 3 Clinical Trials that Assessed Zubsolv® for Induction of Buprenorphine Maintenance Therapy
Regulatory Filings
2014-06-23 English
Positiva resultat från två kliniska Fas 3 studier som utvärderat Zubsolv® för initiering av underhållsbehandling med buprenorfin
Regulatory Filings
2014-06-23 Swedish
Orexo offentliggör obligationsprospekt och ansöker om inregistrering av sitt obligationslån vid NASDAQ OMX Stockholm
Capital/Financing Update
2014-06-09 Swedish
Orexo publishes bond prospectus and applies for listing of its bond loan on NASDAQ OMX Stockholm
Capital/Financing Update
2014-06-09 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2014-05-30 Swedish
Number of shares and votes in Orexo
Share Issue/Capital Change
2014-05-30 English
Orexo ingår nytt samarbete för kommersialiseringen av Zubsolv® i USA
Regulatory Filings
2014-05-20 Swedish
Orexo announces new partner for the commercialization of Zubsolv® in the United States
Regulatory Filings
2014-05-20 English
Orexo har slutfört sin obligationsemission om 500 MSEK
Capital/Financing Update
2014-05-12 Swedish
Orexo has completed its SEK 500 million bond issue
Capital/Financing Update
2014-05-12 English
Orexo issues a SEK 500 million bond loan on the Swedish bond market
Capital/Financing Update
2014-04-30 English
Orexo emitterar obligationslån om 500 MSEK på den svenska obligationsmarknaden
Capital/Financing Update
2014-04-30 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Q1 2014
2014-04-25 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Q1 2014
2014-04-25 English
Kommuniké från Orexo AB:s årsstämma den 15 april 2014
AGM Information
2014-04-15 Swedish
Report from Orexo AB’s annual general meeting, 15 April 2014
AGM Information
2014-04-15 English
Number of shares and votes in Orexo
Declaration of Voting Results & Voting Rights Announcements
2014-03-31 English
Antal aktier och röster i Orexo
Share Issue/Capital Change
2014-03-31 Swedish
Annual Report 2013
Annual Report FY 2013
2014-03-25 Swedish
Annual Report 2013
Annual Report FY 2013
2014-03-25 English
Notice of Annual General Meeting of Orexo
AGM Information
2014-03-14 English
Kallelse till årsstämma i Orexo
AGM Information
2014-03-14 Swedish
Orexo ingår ett exklusivt subventionsavtal med UnitedHealth Group och OptumRx avseende Zubsolv®
Regulatory Filings
2014-03-12 Swedish
Orexo Enters an Exclusive Reimbursement Agreement with UnitedHealth Group and OptumRx for ZUBSOLV®
Regulatory Filings
2014-03-12 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-03-10 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-03-07 English
Number of shares and votes in Orexo
Share Issue/Capital Change
2014-01-31 English
Antal aktier och röster i Orexo
Share Issue/Capital Change
2014-01-31 Swedish
Earnings Release 2013
Earnings Release FY 2013
2014-01-30 Swedish
Earnings Release 2013
Earnings Release FY 2013
2014-01-30 English